SCHEMBL1636060

SCHEMBL1636060

COc1cc(OC)c(/C=C/S(=O)(=O)Nc2ccc(OC)c(OC(=O)c3ccccc3)c2)c(OC)c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.47
LMNA P02545 2/20 0.47
KMT2A Q03164 8/20 0.46
MEN1 O00255 5/20 0.46
MAPT P10636 4/20 0.46
TDP1 Q9NUW8 2/20 0.46
ALOX12 P18054 1/20 0.44
HTT P42858 1/20 0.44
PLK1 P53350 3/20 0.44
MET P08581 1/20 0.44
NQO2 P16083 1/20 0.44
FECH P22830 1/20 0.44
CLK3 P49761 1/20 0.44
HPGD P15428 1/20 0.44
NPSR1 Q6W5P4 1/20 0.42
GHSR Q92847 1/20 0.42
ABCG2 Q9UNQ0 1/20 0.42
CYP3A4 P08684 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
BRAF P15056 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1636064 1.00 ALDH1A1 (0.47) ALDH1A1LMNAKMT2AMEN1MAPT
SCHEMBL1634058 0.90 ABCG2 (0.43) ALDH1A1KMT2AMEN1MAPTTDP1
SCHEMBL1634098 0.88 PLK1 (0.41) ALDH1A1LMNAKMT2AMEN1MAPT
SCHEMBL1634604 0.86 MAPT (0.46) ALDH1A1LMNAKMT2AMEN1MAPT
SCHEMBL1634600 0.86 MAPT (0.46) ALDH1A1LMNAKMT2AMEN1MAPT
SCHEMBL1634052 0.86 LMNA (0.43) ALDH1A1LMNAKMT2AMEN1HTT
SCHEMBL1634057 0.86 LMNA (0.43) ALDH1A1LMNAKMT2AMEN1HTT
SCHEMBL1635162 0.84 ALOX5 (0.49) ALDH1A1LMNAKMT2AMEN1MAPT
SCHEMBL1635203 0.84 PLK1 (0.47) ALDH1A1LMNAMAPTHTTPLK1
SCHEMBL1635200 0.84 PLK1 (0.47) ALDH1A1LMNAMAPTHTTPLK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3138832-A1 SUBSTITUTED PHENOXY- AND PHENYLTHIO- DERIVATIVES FOR TREATING PROLIFERATIVE DISORDERS Temple University - Of The Commonwealth System of Higher Education (US) 2017-03-08 EP claimed
US-20080058290-A1 Substituted Phenoxy-and Phenylthio-Derivatives for Treating Proliferative Disorders TEMPLE UNIVERSITY - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2008-03-06 US claimed
EP-3138832-A1 SUBSTITUTED PHENOXY- AND PHENYLTHIO- DERIVATIVES FOR TREATING PROLIFERATIVE DISORDERS Temple University - Of The Commonwealth System of Higher Education (US) 2017-03-08 EP disclosed
US-7932242-B2 Anticancer agents; radiation and chemical resistance TEMPLE UNIVERSITY - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2011-04-26 US disclosed
US-20080058290-A1 Substituted Phenoxy-and Phenylthio-Derivatives for Treating Proliferative Disorders TEMPLE UNIVERSITY - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2008-03-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080058290-A1 Substituted Phenoxy-and Phenylthio-Derivatives for Treating Proliferative Disorders PCNA, MKI67, TP53 ALDH1A1 564/4885LMNA 2048/4885KMT2A 1779/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.